Trial Details

COMPLETED
Basic Information
Clinical ID c1289
Identifier NCT02435992
Trial Title Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: RPC1063|DRUG: Placebo
Participant Information
Sponsor Celgene
City Sun City
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2015-06-17
Primary Completion Date 2020-03-27
Completion Date 2020-06-17